Industry Provider Profiles Company Type Services
Integrium is a full-service Clinical Research Organization (CRO)
dedicated to the management of cardiovascular and metabolic disease
clinical trials. We combine our focused clinical expertise with
strong operational capabilities to deliver the highest level of
customer care. Within our singular therapeutic focus, our vast
trial experience spans across all stages of clinical development
and stretches around the globe – from single region,
proof-of-concept studies to multinational pivotal trials.
The impressive operational capacity and depth of experience of Integrium is a product of years conducting landmark clinical trials on behalf of our sponsors. Integrium has successfully executed workscopes for a range of companies – including major pharma, biotech, development-stage, device, and diagnostics companies.
Founded and guided by thought leaders in cardiovascular and
metabolic disease research, Integrium has a distinct advantage when
designing and executing cardiovascular and metabolic disease
clinical trials. The clinical expertise of our founders and staff,
as well as to our network of high-enrolling investigators, has
resulted in a proven track record of success.
In addition to our valuable strategic clinical insight and operational excellence, Integrium also provides clients with unparalleled service. Integrium is deeply committed to our clients’ satisfaction throughout the various stages of the clinical trial process. We believe that every client deserves responsive, attentive service – regardless of their size. Our well-managed workscope load enables us to provide this service and we pride ourselves on this fact.
So whether you are a startup biotechnology or a major
pharmaceutical company or any company in between, Integrium wants
to provide value to your next clinical study. By forging a
partnership that seamlessly integrates our processes with yours, we
can help reach common goals while ensuring you receive the
attention you deserve.
Integrium was founded in 1998 by three physicians - Dr. Michael Weber, Dr. David Smith, and Dr. Joel Neutel - each with extensive research experience in the CV and metabolic areas. Integrium is privately-held and headquartered in southern California, with operations in New Jersey and South Africa. The company also has active collaborations with select CROs to provide geographic coverage in Europe and other regions.
As a full-service Clinical Research Organization (CRO), Integrium has the team, experience and quality-assurance measures in place to rapidly and effectively manage cardiovascular and metabolic disease trials of all sizes, in a variety of locations. For the convenience of our customers, we offer each of our services as a stand-alone product as well.
Program Planning and Feasibility
Study Design and Protocol Development
Project Management
Study Startup Services
Site Monitoring
Pharmacovigilance and Medical Safety Monitoring
Data Management
Biostatistics and Statistical Programming
Medical Writing
Cardiovascular Core Laboratory Services (ABPM)
Meeting Planning
We provide centralized Ambulatory Blood Pressure Monitoring (ABPM) services through our Cardiovascular Core Laboratory .
Integrium’s trial experience spans major indications within the cardiovascular and metabolic areas. Integrium has successfully managed trials in all phases of clinical development - representing a broad spectrum of trial complexity and size. This in-depth experience ranges from small proof of concept studies to multinational Phase III studies to large-scale post-marketing studies.
Integrium has experience executing workscopes for a range of chronic and acute care indications, including:
Hyperlipedemia
Acute coronary syndromes
Heart failure
Hypertension
Diabetes
Stroke
Obesity
Metabolic syndrome
Growth disorders
Integrium’s satisfied client list includes a diverse range of sponsors - from major pharmaceutical companies to development stage companies. These companies have entrusted Integrium to manage their trials domestically and internationally, and have consistently expressed their satisfaction with repeat business.
Additionally, Integrium has experience managing significant
morbidity and mortality outcome studies and has coordinated Data
and Safety Monitoring Boards and Endpoint Committees for these
studies.
Debbie Capeldebbie.capel@integrium.com
Eileen McAuleywww.integrium.com View Map Contact Company
If you are interested in contacting this company, please complete and submit the form below. A representative from the company will follow up with you.
